RTA-408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma
{{output}}
Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis owing to its high invasiveness and resistance to therapy. RTA-408, a synthetic triterpenoid and nuclear factor erythroid 2-related factor 2 activator, exhibits anti-inflammatory and anti-cance... ...